Lipid Disorders
From the Journals
Biomarkers linked to elevated T2D MACE risk in DECLARE-TIMI 58
A secondary DECLARE-TIMI 58 trial analysis linked two biomarkers to higher cardiovascular risks in diabetes and found a strong benefit of...
Conference Coverage
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
Two strategies based on electronically delivered letters or “nudges” were found to increase flu shot uptake, compared with usual care, a new study...
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
Latest News
New AHA statement urges focus on CV risk before pregnancy
The emphasis on reducing cardiovascular risk during pregnancy comes too late – the risks have already developed in these patients.
From the Journals
Intermittent fasting plus exercise a good option for fatty liver
“When we compared the results of our study groups, we saw clearly that the most improved patients were in the group that followed the alternate-...
From the Journals
Meta-analysis throws more shade aspirin’s way
A large meta-analysis raises more questions about the benefit of low-dose aspirin in people who don’t have atherosclerotic cardiovascular disease...
From the Journals
Exercise training reduces liver fat in patients with NAFLD, even without weight loss
“Prior to our study, it was felt that body weight loss of at least 5% was required in order to significantly improve liver histology. Our findings...
Commentary
Keto for life? Reasons to think twice
Is the Keto diet best for weight loss? Maybe in the short term, but it’s more complicated than that. Dr. Caroline Apovian explains why.
From the Journals
Persistent gaps in drug use by patients with type 2 diabetes
Continuous use of glucose-, BP-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may...
Commentary
‘Ozempic face’: Accepting wrinkles for improved health
Some who are taking Ozempic are complaining about their faces thinning as an effect of this weight-loss drug. Dr. Anne Peters thinks the benefit...
Commentary
Universal testing for Lp(a): What are we waiting for?
A resurgent interest in molecular pathophysiology this past decade has clarified Lp(a)’s unique contribution to atherothrombotic disease and...